PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT06172127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06172127
- Sponsor
- MedSIR
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2027-04-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.